The use of droperidol before and after the Food and Drug Administration black box warning: a survey of the members of the Society of Ambulatory Anesthesia

Journal of Clinical Anesthesia

Volumn 20, Issue 1, 2008, Pages 35-39

  Habib, Ashraf S ^a   Gan, Tong J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiemetics; Droperidol; Emesis control; FDA black box warning; Postoperative nausea and vomiting

Indexed keywords

ANTIEMETIC AGENT; DEXAMETHASONE; DROPERIDOL; PROMETHAZINE; SCOPOLAMINE; SEROTONIN 3 ANTAGONIST;

ARTICLE; CARDIOVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; DRUG INFORMATION; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HEALTH SURVEY; HEART ARRHYTHMIA; HUMAN; MEDICAL PRACTICE; MEDICAL SOCIETY; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIETY OF AMBULATORY ANESTHESIA;

ANESTHESIA, GENERAL; ANESTHESIOLOGY; ANTIEMETICS; DROPERIDOL; DRUG LABELING; HEALTH CARE SURVEYS; HUMANS; POSTOPERATIVE NAUSEA AND VOMITING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 40749154367     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2007.08.003     Document Type: Article

References (15)

1. White P.F. Droperidol: a cost-effective antiemetic for over thirty years. Anesth Analg 95 (2002) 789-790
2. Gan T.J., Meyer T., Apfel C.C., et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 97 (2003) 62-71
3. Fortney J.T., Gan T.J., Graczyk S., et al. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups. Anesth Analg 86 (1998) 731-738
4. Bailey P.L., Streisand J.B., Pace N.L., et al. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy. Anesthesiology 72 (1990) 977-980
5. Habib A.S., and Gan T.J. Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 96 (2003) 1377-1379
6. Gan T.J., White P.F., Scuderi P.E., Watcha M.F., and Kovac A. FDA "black box" warning regarding use of droperidol for postoperative nausea and vomiting: is it justified?. Anesthesiology 97 (2002) 287
7. White P.F., Song D., Abrao J., Klein K.W., and Navarette B. Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebo-controlled study. Anesthesiology 102 (2005) 1101-1105
8. Zhang Y., Luo Z., and White P.F. A model for evaluating droperidol's effect on the median QTc interval. Anesth Analg 98 (2004) 1330-1335
9. Charbit B., Albaladejo P., Funck-Brentano C., Legrand M., Samain E., and Marty J. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 102 (2005) 1094-1100
10. Hill R.P., Lubarsky D.A., Phillips-Bute B., et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology 92 (2000) 958-967
11. Tang J., Watcha M.F., and White P.F. A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures. Anesth Analg 83 (1996) 304-313
12. Gan T.J. "Black box" warning on droperidol: report of the FDA convened expert panel. Anesth Analg (2004) 98
13. Kim H.L., Gerber G.S., Patel R.V., Hollowell C.M.P., and Bales G.T. Practice patterns in the treatment of female urinary incontinence: a postal and internet survey. Urology 57 (2001) 45-48
14. Dexter F., Smith T.C., Tatman D.J., and Macario A. Physicians' perceptions of minimum time that should be saved to move a surgical case from one operating room to another: internet-based survey of the membership of the Association of Anesthesia Clinical Directors (AACD). J Clin Anesth 15 (2003) 206-210
15. Burmeister L.F. Principles of successful sample surveys. Anesthesiology 99 (2003) 1251-1252